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Recent investigations in this laboratory' have provided evi-dence that the
biosynthesis of nicotinic acid in Neurspora proceeds from tryptophane
through the intermediate kynurenine T.
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Further studies suggested that the pyridine ring of nicotinic acid might
arise by ring closure of the a keto acid corresponding to kynurenine to give
the naturally occurring compound kynurenic acid JJ2 or, if preceded by
oxidation, xanthurenic acid III.'
OH OH
0-COOH QN-COOH
OH
Kynurenic acid II Xanthurenic acid III
In addition to these two compounds a series of nicotinic acid derivatives
was synthesized and tested for growth promoting or growth inhibiting
properties on Neurospora mutant 65001.1 These compounds included: 3-
carboxy-4-hydroxy pyridine, 3-carboxy-4-amino pyridine, 2-hydroxy-3-
carboxy pyridine, 3-carboxy-6-hydroxy pyridine, 2,3-dicarboxy pyridine,
3,4-dicarboxy pyridine, 2,6-dimethyl-3,4-dicarboxy pyridine, 2,3,4-tri-
carboxy-6-methyl pyridine, 3 carboxy-4-chloro pyridine and 2,6-dimethyl-
3-carboxy-4-chloro pyridine. In high concentrations, the compound 3-
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carboxy-4-amino pyridine promoted a small amount of growth, but the re-
maining compounds possessed no stimulatory or inhibitory action under the
conditions utilized.
From the above facts it was concluded that the pyridine ring of nicotinic
acid does not arise from kynurenine through kynurenic acid II or xanth-
urenic acid III followed by oxidation of the benzene ring. It also appeared
evident that the oxidation in position 8 of xanthurenic acid III precedes
formation of the pyridine ring, a possible intermediate being 3-hydroxy-
kynurenine IV.
0
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Hydroxykynurenine IV
A consideration of this hypothetical compound suggested the possibility of
biological oxidation to give 3-hydroxyanthranilic acid (2-amino-3-hydroxy-
benzoic acid) V instead of xanthurenic acid.
Q7COOH
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Hydroxyanthranilic acid V.
A trimethyl derivative of this compound V is indeed found in nature as
the alkaloid damascanine (2-methyl-amino-3-methoxy-methyl benzoate).4 5
The alkaloid has been isolated from the seeds of two species of Nigella
(common name of flowers, Love in a Mist).
It is the purpose of the experimental part of the present paper to present
evidence that hydroxyanthranilic acid is an intermediate in the biological
synthesis of nicotinic acid from tryptophane in Neurospora.
Hydroxyanthranilic acid has been synthesized in this laboratory by two
independent methods. These methods and the proof of structure of the
active compound will be presented elsewhere.
Experimental.-Media and conditions for growth of mutant 65001 have
been previously described.1'6 Growth curves for this mutant in the pres-
ence of nicotinamide and hydroxyanthranilic acid (filter sterilized) are pre-
sented in figure 1. For these experiments the pH of the medium was
adjusted to 4.1 since hydroxyanthranilic acid, like nicotinic acid, is less
active at a higher pH where dissociation is greater. In four days at a pH
of 5.6 the compound is 50 to 70% as effective as nicotinamide in promoting
growth. It is thus more effective than nicotinic acid at pH 5.6.7
The growth-promloting activity of hydroxyanthranilic acid on several
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FIGURE 1
Growth curves of mutant 65001 (61/2 days) in the presence of nicotinamide (curve
N) and hydroxyanthranilic acid (curve HA).
genetically different mutants of Neurospora was compared to that of
anthranilic acid, indole, tryptophane, kynurenine and nicotinamide, and
qualitativ.e data is presented in table 1.
TABLE 1
ACTIVITY OF HYDROXYANTHRANILIc ACID COMPARED TO ANTHRANILIC ACID, INDOLE,
TRYPTOPHANE, KYNURENINE AND NICOTINAMIDE ON Neurospora MUTANTS
HYDROXY-
MUTANT ANTHRA- TRYPTO- ANTHRANILIC NICOTINA-
STRAIN NILIC ACID INDOLE PHANE KYNURBNINE ACIED IDE
44008 - + + + + +
65001 - + + + + +
39401 - + + + + +
4540 - - _ - - +
3416 - ±
It was previously shown' that an excess of a compound with nicotinamide
activity is produced by mutant 65001 when it is grown in the presence of an
3
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excess of kynurenine. Similar experiments with hydroxyanthranilic acid
are summarized in table 2. Nicotinic amide activity was determined by
use of strain 3416 which does not utilize hydroxyanthranilic acid. Deter-
minations were made on culture fluids of six-day-old cultures of 65001 and
44008 grown in the presence of various quantities of hydroxyanthranilic
acid.
TABLE 2
PRODUCTION OF NICOTINAMIDE ACTIVITY FROM HYDROXYANTHRANILIC ACID BY MUTANTS
65001 AND 44008
NICOTINAMIDE ACTIVITY, JG. PER 20 ML.
HYDROXYANTHRANILIC --DRY WEIGHT--' OF CULTURE FLUID
ACID, AG. PBR 20 ML. 65001 44008 65001 44008
0 2 0 0 0
20 84 97 0 0
50 97 95 0 0
100 108 94 10 12
200 103 85 12 12
Discussion.-It is evident from the experimental data presented, that for
certain Neurospora mutants, hydroxyanthranilic acid possesses growth-
promoting activity that is quite comparable to the activity of nicotinamide.
In addition it has been demonstrated that in the presence of an excess of
hydroxyanthranilic acid two of the Neurospora mutants produce an excess
of a substance with the biological activity of nicotinic acid or nicotinamide.
This was determined by use of a mutant that utilizes either of the latter two
compounds but does not utilize hydroxyanthranilic acid.
Thus it appears probable that this substance is a natural intermediate in
the biological synthesis of nicotinic acid by the mold Neurospora. It is of
interest to note the complex series of reactions that are required by the
mold to convert anthranilic acid to hydroxyanthranilic acid. These reac-
tions are illustrated schematically in figure 2.
No comparison has been made, in this laboratory, between the properties
of hydroxyanthranilic'acid and those of the nicotinic acid precursor from
Neurospora described by Bonner and Beadle.7 From the published data it
can be seen that the molecular formula is similar. The isolated precursor,
however, is reported to be a pyridine derivative. As such it would be ex-
pected to be further along in the series of reactions leading to nicotinic acid
synthesis. In this connection it may be suggested that hydroxyanthranilic
acid can be converted to nicotinic acid by oxidation and loss of carbon three
of the compound, followed by ring closure or rearrangement in the six car-
bon amino acid residue. If this occurs iin animals and in Neurospora the 3-
carboxy-6-pyridone isolated by Knox and Grossman8 may well be a by-
product of the reaction. Similarly, the occurrence of damascanine in
Nigella may be accounted for as resulting from a side reaction in the bio-
synthesis of nicotinic acid in the organism.
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FIGURE 2
A schematic representation of a series of reactions leading to the biosynthesis of
nicotinic acid in Neurospora.
Summary.-1. Evidence is presented to show that hydroxyanthranilic
acid (2-amino-3-hydroxy benzoic acid) is an intermediate in the biosynthe-
sis of nicotinic acid in Neurospora.
2. Several nicotinic acid derivatives and other related compounds are
shown to lack significant biological activity.
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Communicated by E. W. Sinnott, December 11, 1947
In a previous paper' the production and isolation of a natural precursor
of nicotinic acid was described. The present paper deals with the identi-
fication of this precursor.
Several mutant strains of Neurospora crassa have been characterized as
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